Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-06-27

Clinical Trial Update: VF Test for Prediction of Extremely PTB After Cerclage

View source ↗

Summary

The clinical trial evaluating the VF Test for predicting extremely preterm birth after cerclage has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pediatrix | Conditions: Preterm Birth, Infection | Status: WITHDRAWN